Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Bortezomib-Based Induction Treatment for Patients with Multiple Myeloma Ineligible for Autologous Stem Cell Transplantation: A Retrospective Multicenter Study in Czech Republic

Viera Sandecka, MD, Ludek Pour, Doc,MD PhD, Sabina Sevcikova, RNDr, PhD, Lucie Brozova, MSc, Jan Straub, MD, Vlastimil Scudla, Prof, MD CSc, Vladimir Maisnar, Prof, MD PhD, Petr Pavlicek, MD, Zdenek Adam, Prof, MD CSc, Marta Krejci, Prof, MD PhD, Martin Stork, MD, Tomas Jelinek, Hana Plonkova, Roman Hajek

Blood (2017) 130 (Supplement 1): 5435.

https://doi.org/10.1182/blood.V130.Suppl_1.5435.5435

Published: 2017

Journal Articles

Does Your Smoldering Myeloma Patient Need Treatment? Evidence Based Recommendations

Rafiullah, MD, Umar Zahid, MD, Irbaz Bin Riaz, MDMMSc, Ali McBride, PharmD,MS, Ahmad Iftikhar, MD, Yogesh Jethava, MBBS,MDFRCPath,MRCP, Guido J. Tricot, MD PhD, Faiz Anwer, MD

Blood (2017) 130 (Supplement 1): 5431.

https://doi.org/10.1182/blood.V130.Suppl_1.5431.5431

Published: 2017

Journal Articles

Predictors of Overall Survival (OS) in Patients with Multiple Myeloma (MM) Initiating First- and Second-Line Treatment in the Czech Republic

Roman Hájek, Jarkovsky Jiri, Bouwmeester Walter, Treur Maarten, DeCosta Lucy, Campioni Marco, Brozova Lucie, Gonzalez-McQuire Sebastian

Blood (2016) 128 (22): 3607.

https://doi.org/10.1182/blood.V128.22.3607.3607

Published: 2016

Journal Articles

Multiple Myeloma in Patients with HCV-Related Disease:a Case Report

Iolanda D. Vincelli, Patrizia Cufari, Francesco Di Raimondo, MD, Martino Massimo, Massimo Gentile, MD, Fortunato Morabito, Stefania Ciolli, Marco Rossi, MD, Francesca Ronco

Blood (2016) 128 (22): 5700.

https://doi.org/10.1182/blood.V128.22.5700.5700

Published: 2016

Journal Articles

AMPK Expressed By Multiple Myeloma Cells Inhibited Metformin-Induced Myeloma Cells Proliferation

Fuming Zi, PhD, Jingsong He, Enfan Zhang, M.MD, Yang Yang, PhD, He Huang, MD PhD, Qing Yi, MD PhD, Zhen Cai, MD PhD

Blood (2016) 128 (22): 5703.

https://doi.org/10.1182/blood.V128.22.5703.5703

Published: 2016

Journal Articles

Exploration of Survival Stratification of Patients with Multiple Myeloma after First Relapse Using Real World Data

Roman Hájek, Jiri Jarkovsky, MSc, PhD, Walter Bouwmeester, Maarten Treur, Lucy DeCosta, Marco Campioni, Michel Delforge, Marc S. Raab, MD, Paul Schoen, Zsolt Szabo, MD, Brozova Lucie, Sebastian Gonzalez-McQuire

Blood (2016) 128 (22): 2417.

https://doi.org/10.1182/blood.V128.22.2417.2417

Published: 2016

Journal Articles

Cytogenetic Abnormalities of Undetermined Clinical Significance Correlate with Poor Prognosic Factors in Multiple Myeloma

Young Kyung Lee, MD PhD, Miyoung Kim, MD PhD, Eun Jin Lee, MD, Hee Jung Kang, MD PhD, Han-Sung Kim, MD PhD, Hyoun Chan Cho, MD PhD, Hyo Jung Kim, MD PhD, Dong Soon Lee, MD PhD

Blood (2014) 124 (21): 2041.

https://doi.org/10.1182/blood.V124.21.2041.2041

Published: 2014

Journal Articles

Calreticulin mRNA Expression Levels and Clinicopathologic Characteristics in Hematologic Malignancies

Sholhui Park, MD, Hee Jin Huh, Yeung Chul Mun, Chu-Myong Seong, Wha Soon Chung, Jungwon Huh

Blood (2014) 124 (21): 5184.

https://doi.org/10.1182/blood.V124.21.5184.5184

Published: 2014

Journal Articles

Serum Level Of Parathyroid Hormone Is Associated With Risk Factors and Clinical Outcomes In Multiple Myeloma

Min-Gu Kang, MD, Min-Joong Jang, O-jin Lee, Min-Seok Heo, Hyun-Woo Choi, MD, Hwan-Young Kim, Nguyen Thi Dai Trang, Deok-Hwan Yang, Je-Jung Lee, Jong-Hee Shin, MD, PhD, Soon-Pal Suh, MD, Ph.D, Dong-Wook Ryang, MD., Ph.D, Hye-Ran Kim, PhD, Myung-Geun Shin, MD, PhD

Blood (2013) 122 (21): 5365.

https://doi.org/10.1182/blood.V122.21.5365.5365

Published: 2013

Journal Articles

Fibroblast Activation Protein Protects Bortezomib Induced Apoptosis In Multiple Myeloma Cells Through β-Catenin Signaling Pathway

Fuming Zi, M.Med, Jingsong He, MD, PhD, Donghua He, PhD, Yi Li, M.Med, Li Yang, M.Med, Lijuan Wang, PhD, Yang Yang, PhD, Yi Zhao, PhD, Wenjun Wu, M.Med, He Huang, MD, PhD., Qing Yi, MD, PhD, Zhen Cai, MD, PhD

Blood (2013) 122 (21): 3083.

https://doi.org/10.1182/blood.V122.21.3083.3083

Published: 2013

Journal Articles

Improvement in Clinical Benefit Parameters with Pomalidomide (POM) in Combination with Low-Dose Dexamethasone (LoDEX) in Patients with Relapsed and Refractory Multiple Myeloma (RRMM): Results From a Phase 2 Study

Sagar Lonial, MD, Rachid Baz, MD, Nizar J. Bahlis, MD, Christine I. Chen, MD, Kenneth C. Anderson, MD, Min Chen, PhD, Mohamed Zaki, MD, Paul G. Richardson, MD

Blood (2012) 120 (21): 4052.

https://doi.org/10.1182/blood.V120.21.4052.4052

Published: 2012

Journal Articles

Clinical and Epidemiological Characteristics of Multiple Myeloma (MM): Comparison Between Hematopoietic Stem Cell Transplantation (HSCT) and Conventional Chemotherapy,

Gemma Ramirez, Consuelo Gonzalez Garcia, Ma Sol Durán, Javier De La Rubia, Alfons Soler, Inmaculada Castillo, Manuel Jurado, Paz Ribas, Ma Carmen Menchaca Echevarría, Miguel T. Hernandez, Ma Dolores López García-Carreño, Asunción Echeveste Gutierrez, Alicia Bailén Garcia, Silvia López, Jose Baquero

Blood (2011) 118 (21): 4166.

https://doi.org/10.1182/blood.V118.21.4166.4166

Published: 2011

Journal Articles

Military Service in Vietnam/Korea and Serum Dioxin Levels Do Not Affect the Outcomes of Patients Diagnosed with Plasma Cell Dyscrasias

Prasanth Ganesan, MD, Emil Kuriakose, MD, Carla Smith, Robert T Harris, Jonathan E Dowell, MD, Arnold Schecter, Simrit Parmar, M.D.

Blood (2011) 118 (21): 5098.

https://doi.org/10.1182/blood.V118.21.5098.5098

Published: 2011

Journal Articles

Hypercalcemia Following Treatment with Lenalidomide in Chronic Lymphocytic Leukemia (CLL).

Bijal D. Shah, MD, Marays Veliz, MD, Ricardo Santana, Jeffrey E Lancet, MD, John J. Powers, B.S., Jason A Dubovsky, B.S., Sara Tinsley, Darcie Deaver, ANP, MS, Eduardo M. Sotomayor, MD, Javier Pinilla, MD, PhD

Blood (2009) 114 (22): 4413.

https://doi.org/10.1182/blood.V114.22.4413.4413

Published: 2009

Journal Articles

Phosphatidic Acid Enhances Procoagulant Activity and Thrombosis through Phosphatidylserine Exposure in Human Erythrocytes.

Ji-Yoon Noh, Kyung-Min Lim, Jin-Ho Chung

Blood (2008) 112 (11): 3846.

https://doi.org/10.1182/blood.V112.11.3846.3846

Published: 2008

Journal Articles

A Critical Analysis of Prognostic Factors in Patients with HTLV-1 Adult T-Cell Leukemia/Lymphoma: A Multicenter Clinicopathologic Experience and New Prognostic Score.

Adrienne A. Phillips, MD, MPH, Iuliana Shapira, MD, Robert D. Willum, BS, Jasotha Sanmugarajah, MD, William B. Solomon, MD, Steven M. Horwitz, MD, David G. Savage, MD, Govind Bhagat, MD, Gerald Soff, MD, Jasmine M. Zain, MD, Bashir Alobeid, MD, Venkatraman E. Seshan, PhD, Owen A. O’Connor, MD, PhD

Blood (2008) 112 (11): 1784.

https://doi.org/10.1182/blood.V112.11.1784.1784

Published: 2008

Journal Articles

A Multicenter Clinicopathologic Experience of HTLV-1 ATLL: A Retrospective 15 Year Review Reveals Little Progress.

Adrienne A. Phillips, MD, MPH, Iuliana Shapira, MD, Robert D. Willim, BS, Jasotha Sanmugarajah, MD, William B. Solomon, MD, Steven M. Horwitz, MD, David G. Savage, MD, Gerald Soff, MD, Owen A. O’Connor, MD, PhD

Blood (2007) 110 (11): 3569.

https://doi.org/10.1182/blood.V110.11.3569.3569

Published: 2007

Journal Articles

Rapid Activation of Unstimulated Endothelial Cells Containing Tissue Factor Following Laser-Induced Injury as Monitored Via Calcium Mobilization.

Ben T. Atkinson, DPhil, Cynthia A. Kos, MS, Barbara C. Furie, PhD, Bruce Furie, MD

Blood (2006) 108 (11): 1786.

https://doi.org/10.1182/blood.V108.11.1786.1786

Published: 2006

Journal Articles

Extremely Elevated Lactate Dehydrogenase and Aspartate Aminotransferase Level as an Indicator of Tumor Lysis during Bortezomib Treatment in a Multiple Myeloma Patient: Case Report.

Xuemei Sun, MD, Jiangang Yang, BS, Bin Chen, MD

Blood (2006) 108 (11): 5123.

https://doi.org/10.1182/blood.V108.11.5123.5123

Published: 2006

Journal Articles

Clinical Evaluation of Bone Mineral Density (BMD) and Bone Metabolism in Hereditary Hemochromatosis (HH).

Yu Ying Yau, Charles D. Bolan, Stacey A. Cecco, Nadja N. Rehak, Michael Collins, James Reynolds, Susan F. Leitman

Blood (2005) 106 (11): 3727.

https://doi.org/10.1182/blood.V106.11.3727.3727

Published: 2005

NARROW

Bortezomib-Based Induction Treatment for Patients with Multiple Myeloma Ineligible for Autologous Stem Cell Transplantation: A Retrospective Multicenter Study in Czech Republic

Does Your Smoldering Myeloma Patient Need Treatment? Evidence Based Recommendations

Predictors of Overall Survival (OS) in Patients with Multiple Myeloma (MM) Initiating First- and Second-Line Treatment in the Czech Republic

Multiple Myeloma in Patients with HCV-Related Disease:a Case Report

AMPK Expressed By Multiple Myeloma Cells Inhibited Metformin-Induced Myeloma Cells Proliferation

Exploration of Survival Stratification of Patients with Multiple Myeloma after First Relapse Using Real World Data

Cytogenetic Abnormalities of Undetermined Clinical Significance Correlate with Poor Prognosic Factors in Multiple Myeloma

Calreticulin mRNA Expression Levels and Clinicopathologic Characteristics in Hematologic Malignancies

Serum Level Of Parathyroid Hormone Is Associated With Risk Factors and Clinical Outcomes In Multiple Myeloma

Fibroblast Activation Protein Protects Bortezomib Induced Apoptosis In Multiple Myeloma Cells Through β-Catenin Signaling Pathway

Improvement in Clinical Benefit Parameters with Pomalidomide (POM) in Combination with Low-Dose Dexamethasone (LoDEX) in Patients with Relapsed and Refractory Multiple Myeloma (RRMM): Results From a Phase 2 Study

Clinical and Epidemiological Characteristics of Multiple Myeloma (MM): Comparison Between Hematopoietic Stem Cell Transplantation (HSCT) and Conventional Chemotherapy,

Military Service in Vietnam/Korea and Serum Dioxin Levels Do Not Affect the Outcomes of Patients Diagnosed with Plasma Cell Dyscrasias

Hypercalcemia Following Treatment with Lenalidomide in Chronic Lymphocytic Leukemia (CLL).

Phosphatidic Acid Enhances Procoagulant Activity and Thrombosis through Phosphatidylserine Exposure in Human Erythrocytes.

A Critical Analysis of Prognostic Factors in Patients with HTLV-1 Adult T-Cell Leukemia/Lymphoma: A Multicenter Clinicopathologic Experience and New Prognostic Score.

A Multicenter Clinicopathologic Experience of HTLV-1 ATLL: A Retrospective 15 Year Review Reveals Little Progress.

Rapid Activation of Unstimulated Endothelial Cells Containing Tissue Factor Following Laser-Induced Injury as Monitored Via Calcium Mobilization.

Extremely Elevated Lactate Dehydrogenase and Aspartate Aminotransferase Level as an Indicator of Tumor Lysis during Bortezomib Treatment in a Multiple Myeloma Patient: Case Report.

Clinical Evaluation of Bone Mineral Density (BMD) and Bone Metabolism in Hereditary Hemochromatosis (HH).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only